TNSN97014A1 - Piperidones, procedes pour leur preparation et compositions pharmaceutiques les contenant. - Google Patents

Piperidones, procedes pour leur preparation et compositions pharmaceutiques les contenant.

Info

Publication number
TNSN97014A1
TNSN97014A1 TNTNSN97014A TNSN97014A TNSN97014A1 TN SN97014 A1 TNSN97014 A1 TN SN97014A1 TN TNSN97014 A TNTNSN97014 A TN TNSN97014A TN SN97014 A TNSN97014 A TN SN97014A TN SN97014 A1 TNSN97014 A1 TN SN97014A1
Authority
TN
Tunisia
Prior art keywords
preparation
processes
compositions containing
piperidones
pharmaceutical compositions
Prior art date
Application number
TNTNSN97014A
Other languages
English (en)
Inventor
Roderick Mackenzie Alexander
Patrick Marchington Allan
Stuart Middleton Donald
Dora Meadows Sandra
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of TNSN97014A1 publication Critical patent/TNSN97014A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

L'INVENTION CONCERNE DES COMPOSES DE FORMULE ( I) DANS LAQUELLE X REPRESENTE UNE LIAISON DIRECTE OU UN GROUPE ALKYLENE EN C1 A C4 ET R REPRESENTE UN GROUPE CYCLOALKYLE EN C3 A C7 FACULTATIVEMENT SUBSTITUE. ELLE CONCERNE DES PROCEDES POUR LEUR PREPARATION, LES INTERMEDIAIRES UTILISES ET DES COMPOSITIONS LES CONTENANT. UTILISATION DE CES COMPOSES ET COMPOSITIONS COMME ANTAGONISTES DES TACHYKININES DANS LE TRAITEMENT DE DIVERSES MALADIES.
TNTNSN97014A 1996-01-22 1997-01-21 Piperidones, procedes pour leur preparation et compositions pharmaceutiques les contenant. TNSN97014A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9601202.6A GB9601202D0 (en) 1996-01-22 1996-01-22 Piperidones

Publications (1)

Publication Number Publication Date
TNSN97014A1 true TNSN97014A1 (fr) 2005-03-15

Family

ID=10787341

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN97014A TNSN97014A1 (fr) 1996-01-22 1997-01-21 Piperidones, procedes pour leur preparation et compositions pharmaceutiques les contenant.

Country Status (16)

Country Link
US (1) US6262075B1 (fr)
EP (1) EP0888337B1 (fr)
JP (1) JP3140063B2 (fr)
AT (1) ATE218563T1 (fr)
AU (1) AU1442297A (fr)
CA (1) CA2240964C (fr)
CO (1) CO4560412A1 (fr)
DE (1) DE69713075T2 (fr)
DK (1) DK0888337T3 (fr)
ES (1) ES2175328T3 (fr)
GB (1) GB9601202D0 (fr)
HR (1) HRP970040A2 (fr)
MA (1) MA26418A1 (fr)
PT (1) PT888337E (fr)
TN (1) TNSN97014A1 (fr)
WO (1) WO1997027185A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9600235D0 (en) * 1996-01-05 1996-03-06 Pfizer Ltd Therapeutic agents
WO1999019297A1 (fr) * 1997-10-15 1999-04-22 Coelacanth Chemical Corporation Synthese de derives d'azetidine
HUP0004321A3 (en) * 1997-12-04 2002-04-29 Sankyo Co Alicyclic acylated heterocyclic derivatives and pharmaceutical compositions containing the same
GB9812037D0 (en) * 1998-06-04 1998-07-29 Pfizer Ltd Piperidones
GB9924141D0 (en) * 1998-10-30 1999-12-15 Zeneca Ltd Treatment of gastric asthma
GB0005366D0 (en) * 2000-03-06 2000-04-26 Xenova Ltd Pharmaceutical compounds
TW200508221A (en) 2003-06-13 2005-03-01 Astrazeneca Ab New azetidine compounds
US20040265238A1 (en) 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
DE10336274A1 (de) * 2003-08-07 2005-03-10 Honeywell Specialty Chemicals Verfahren zur Herstellung von geminalen Difluoralkanen
CA2612133A1 (fr) * 2005-06-23 2006-12-28 Astrazeneca Ab Nouveaux derives d'azetidine utiles comme antagonistes des recepteurs de la neurokinine dans le traitement des maladies gastro-intestinales
EP1899318A4 (fr) * 2005-06-23 2010-03-17 Astrazeneca Ab Nouveaux derives d'azetidine utiles en tant qu'antagonistes des recepteurs des neurokinines employes pour le traitement des maladies gastro-intestinales
AR057828A1 (es) 2005-09-29 2007-12-19 Astrazeneca Ab Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica
AR056087A1 (es) * 2005-09-29 2007-09-19 Astrazeneca Ab Derivados de azetidina como antagonistas de receptores de neuroquina nk
US8106208B2 (en) 2006-05-18 2012-01-31 Albireo Ab Benzamide compounds that act as NK receptor antagonists
EP2129381A1 (fr) 2007-01-24 2009-12-09 Glaxo Group Limited Nouvelles compositions pharmaceutiques
AR074755A1 (es) * 2008-12-16 2011-02-09 Astrazeneca Ab Derivados cuaternarios de piperidina y sus usos
ES2550939T3 (es) 2010-07-16 2015-11-13 Nivalis Therapeutics, Inc. Nuevos compuestos de dihidropiridin-2-(1H)-ona como inhibidores de la S-nitrosoglutatión reductasa y antagonistas del receptor de la neurocinina-3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676055B1 (fr) 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
TW432061B (en) * 1994-08-09 2001-05-01 Pfizer Res & Dev Lactams
FR2729951B1 (fr) * 1995-01-30 1997-04-18 Sanofi Sa Nouveaux composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques en contenant

Also Published As

Publication number Publication date
WO1997027185A1 (fr) 1997-07-31
DE69713075D1 (de) 2002-07-11
US6262075B1 (en) 2001-07-17
CA2240964C (fr) 2002-06-25
AU1442297A (en) 1997-08-20
CO4560412A1 (es) 1998-02-10
CA2240964A1 (fr) 1997-07-31
PT888337E (pt) 2002-09-30
ES2175328T3 (es) 2002-11-16
JPH11505271A (ja) 1999-05-18
DE69713075T2 (de) 2003-02-27
GB9601202D0 (en) 1996-03-20
DK0888337T3 (da) 2002-07-01
HRP970040A2 (en) 1998-06-30
EP0888337A1 (fr) 1999-01-07
JP3140063B2 (ja) 2001-03-05
ATE218563T1 (de) 2002-06-15
MA26418A1 (fr) 2004-12-20
EP0888337B1 (fr) 2002-06-05

Similar Documents

Publication Publication Date Title
TNSN97014A1 (fr) Piperidones, procedes pour leur preparation et compositions pharmaceutiques les contenant.
WO2002098856A3 (fr) Antagonistes du recepteur d'adenosine diphosphate plaquettaire
TW367327B (en) Heterocyclic compounds having tachykinin receptor antagonist activity, their preparation and their use
DE69725608D1 (de) Indolin-2-one derivate, verfahren zu ihrer herstellung und dieseenthaltende arzneimittel
ES8602763A1 (es) Un procedimiento para la preparacion de n-(heterociclilbiciclo)-4-piperidinaminas.
PT894084E (pt) Derivados de acido cinamico e sua utilizacao como antagonistas de integrina
ES2137998T3 (es) Nuevos derivados de aminoacidos, procedimiento para su preparacion y composiciones farmaceuticas que contienen estos compuestos.
IL111960A (en) Morpholines and thiomorpholines their preparation and pharmaceutical compositions containing them
IL109496A0 (en) Substituted pyrrolidin-3-yl-alkyl-piperidines and pharmaceutical compositions containing them
DE69422303T2 (de) Neue 4-piperidinyl substituierte lactame als neukokinin 2 rezeptor antagonisten zur behandlung von asthma
EA199800794A1 (ru) Новые производные арилглициламида, способ их получения и фармацевтическая композиция, содержащая эти соединения
PL322768A1 (en) Novel derivatives of aryloglysinamide, methods of obtaining them and pharmaceutic compositions containing such compounds
ES2087038A1 (es) Nuevas piperidinas con actividad antagonista del paf.
NO973652L (no) 5-(4-subst.-piperidinyl-1)-3-aryl-pentansyrederivater som tachykininreseptor-antagonist
TR199801268T2 (xx) Ta�ikinin antagonistleri olarak 3-Azetidinilalkilpiperidinler veya pirolidinler.
PT962457E (pt) Piperidonas como antagonistas de taquicinina
UY26971A1 (es) Nuevos antagonistas de neuroquinina, procedimiento para su preparación y composiciones farmacéuticas que contienen estos compuestos
UY26972A1 (es) Nuevos antagonistas de neuroquinina, procedimiento para su preparación y composiciones farmacéuticas que contienen estos compuestos
CA2180660A1 (fr) Nouveaux derives piperidines a activite antagoniste du facteur paf